Commercial analysis
2025WaitWise
Commercial analysis of an AI clinical decision support product: market sizing, NHS adoption barriers, procurement context and commercialisation strategy.
The work
A consulting-grade commercial analysis of WaitWise, an AI clinical decision support product: bottom-up market sizing, a clear-eyed read of NHS adoption barriers (evidence thresholds, information governance, integration burden) and the procurement context that decides whether a good product ever reaches a ward.
Why it matters
Most health tech commercialisation fails on distribution, not product. The analysis maps who actually buys, on what budget cycle and against what evidence bar, then turns that into a commercialisation strategy a founder or board can execute rather than admire.
Next step
Get in touch.
A thirty-minute call is enough to tell whether I can help. If I can, you'll get a scoped proposal: defined deliverables, a fixed fee or day rate, and a start date. If I can't, I'll say so on the call.
Open to short-term contracts, fixed-scope projects and part-time roles.